This is the second of six webinars which will be held virtually during the months of February and March 2021 to provide guidance on pharmacogenomics and understand the health equity implications of adoption.
The webinars are sponsored by AMA and ASHP (American Society of Health-System Pharmacists).
Current state of pharmacogenomics
Gain insights into Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and the FDA perspective, and hear best practices from early adopters.
This webinar will:
- Discuss the process for developing CPIC guidelines
- Describe the FDA perspective on pharmacogenomics
- Recognize differences between CPIC guidelines and FDA warning labels
- Identify best practices from leading institutions in the field of pharmacogenomics
U. Broeckel, MD
- Professor of pediatrics, medicine and physiology
- Chief—Section of genomic pediatrics, department of pediatrics, associate director, Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin
- Founder and CEO, RPRD Diagnostics LLC, Milwaukee, Wisconsin
- Introduction—Ulrich Broeckel, MD
- Development of CPIC guidelines—Kelly E. Caudle, PharmD, PhD, BCPS, FCCP (St. Jude Children’s Research Hospital)
- FDA perspective—Timothy T. Stenzel, MD, PhD (FDA)
- Personalized Medicine Coalition: Gap analysis—Daryl Pritchard, PhD (Personalized Medicine Coalition)
- Current state: NorthShore—Henry “Mark” Dunnenberger, PharmD BCPS (NorthShore University HealthSystem)
- Current state: University of Florida—Larisa H. Cavallari, PharmD, BCPS, FCCP
- Current state: St. Jude Children's Research Hospital—Mary V. Relling, Pharm.D
- Future directions & wrap-up
ASHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This jointly sponsored online activity will offer two hours of CPE credit to pharmacists or CME credit to physician attendees. Pharmacists and physicians are eligible to receive a total of 12.00 hours of continuing education credit by attending all six events.
Participants must participate in the entire activity, complete the evaluation and all required components to claim continuing education credit online at ASHP eLearning Portal. Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.
Visit the Pharmacogenomics Virtual Summit Series page for information on other summits in the series.